Oedema. Somnolence, dizziness, headache, dysgeusia, paraesthesia, vertigo, visual impairment, diplopia, tinnitus, palpitations, flushing, hypotension, dyspnea, cough, abdominal pain, nausea, vomiting, dyspepsia, change of bowel habit, diarrhoea, constipation, pruritus, rash, exanthema, joint swelling (ankle swelling), muscle spasms, fatigue, asthenia. Rhinitis, eosinophilia, hypersensitivity, hypoglycaemia, hyperkalaemia, hyponatraemia, insomnia, altered mood, anxiety, depression, sleep disorder, tremor, hypoaesthesia, syncope, tachycardia, arrhythmia (including bradycardia, ventricular tachycardia & atrial fibrillation), vasculitis, bronchospasm, dry mouth, angioedema of face, extremities, lips, mucous membranes, tongue, glottis &/or larynx, alopecia, purpura, skin discolouration, hyperhidrosis, urticaria, photosensitivity reactions, pemphigoid, arthralgia, myalgia, back pain, micturition disorders, nocturia, pollakiuria, renal failure, erectile dysfunction, gynaecomastia, peripheral oedema, chest pain, pain, malaise, pyrexia, increased or decreased wt, increased blood urea & creatinine, fall. Confusional state, psoriasis aggravation, increased blood bilirubin & hepatic enzyme. Leukopenia/neutropenia, agranulocytosis or pancytopenia, thrombocytopenia, haemolytic anaemia enzyme specific in patients w/ a congenital deficiency of G6PDH, hyperglycaemia, hypertonia, peripheral neuropathy, CVA possibly secondary to excessive hypotension in high-risk patients, angina pectoris, MI, eosinophilic pneumonia, gingival hyperplasia, pancreatitis, gastritis, hepatitis, jaundice, hepatitis either cytolytic or cholestatic, hepatic enzymes increased, Quincke’s oedema, erythema multiforme, SJS, exfoliative dermatitis, acute renal failure, decreased Hb & haematocrit. Extrapyramidal disorder (extrapyramidal syndrome), TEN & Raynaud’s phenomenon. SIADH can be considered as a very rare complication associated w/ ACE inhibitor therapy.
Sign Out
